324 related articles for article (PubMed ID: 2783259)
1. Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses.
Golemis E; Li Y; Fredrickson TN; Hartley JW; Hopkins N
J Virol; 1989 Jan; 63(1):328-37. PubMed ID: 2783259
[TBL] [Abstract][Full Text] [Related]
2. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides.
Li Y; Golemis E; Hartley JW; Hopkins N
J Virol; 1987 Mar; 61(3):693-700. PubMed ID: 3468264
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factors that bind to the enhancer region of nondefective Friend murine leukemia virus.
Manley NR; O'Connell MA; Sharp PA; Hopkins N
J Virol; 1989 Oct; 63(10):4210-23. PubMed ID: 2778872
[TBL] [Abstract][Full Text] [Related]
4. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses.
Ishimoto A; Takimoto M; Adachi A; Kakuyama M; Kato S; Kakimi K; Fukuoka K; Ogiu T; Matsuyama M
J Virol; 1987 Jun; 61(6):1861-6. PubMed ID: 3033317
[TBL] [Abstract][Full Text] [Related]
5. Long terminal repeat of Friend-MCF virus contains the sequence responsible for erythroid leukemia.
Ishimoto A; Adachi A; Sakai K; Matsuyama M
Virology; 1985 Feb; 141(1):30-42. PubMed ID: 3856371
[TBL] [Abstract][Full Text] [Related]
6. A 3' end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus.
Chatis PA; Holland CA; Silver JE; Frederickson TN; Hopkins N; Hartley JW
J Virol; 1984 Oct; 52(1):248-54. PubMed ID: 6090701
[TBL] [Abstract][Full Text] [Related]
7. Envelope gene and long terminal repeat determine the different biological properties of Rauscher, Friend, and Moloney mink cell focus-inducing viruses.
Vogt M; Haggblom C; Swift S; Haas M
J Virol; 1985 Jul; 55(1):184-92. PubMed ID: 4009793
[TBL] [Abstract][Full Text] [Related]
8. Role for the 3' end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses.
Chatis PA; Holland CA; Hartley JW; Rowe WP; Hopkins N
Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4408-11. PubMed ID: 6308622
[TBL] [Abstract][Full Text] [Related]
9. A DNA element responsible for the different tissue specificities of Friend and Moloney retroviral enhancers.
Thiesen HJ; Bösze Z; Henry L; Charnay P
J Virol; 1988 Feb; 62(2):614-8. PubMed ID: 2826819
[TBL] [Abstract][Full Text] [Related]
10. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity.
Speck NA; Renjifo B; Golemis E; Fredrickson TN; Hartley JW; Hopkins N
Genes Dev; 1990 Feb; 4(2):233-42. PubMed ID: 2338244
[TBL] [Abstract][Full Text] [Related]
11. Tissue tropism of a leukemogenic murine retrovirus is determined by sequences outside of the long terminal repeats.
Wolff L; Ruscetti S
Proc Natl Acad Sci U S A; 1986 May; 83(10):3376-80. PubMed ID: 3010293
[TBL] [Abstract][Full Text] [Related]
12. Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers.
Manley NR; O'Connell M; Sun W; Speck NA; Hopkins N
J Virol; 1993 Apr; 67(4):1967-75. PubMed ID: 8445718
[TBL] [Abstract][Full Text] [Related]
13. Characterization of enhancer elements in the long terminal repeat of Moloney murine sarcoma virus.
Laimins LA; Gruss P; Pozzatti R; Khoury G
J Virol; 1984 Jan; 49(1):183-9. PubMed ID: 6690710
[TBL] [Abstract][Full Text] [Related]
14. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
Hanecak R; Pattengale PK; Fan H
J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
[TBL] [Abstract][Full Text] [Related]
15. Introduction of a cis-acting mutation in the capsid-coding gene of moloney murine leukemia virus extends its leukemogenic properties.
Audit M; Déjardin J; Hohl B; Sidobre C; Hope TJ; Mougel M; Sitbon M
J Virol; 1999 Dec; 73(12):10472-9. PubMed ID: 10559365
[TBL] [Abstract][Full Text] [Related]
16. Sequences responsible for the distinctive hemolytic potentials of Friend and Moloney murine leukemia viruses are dispersed but confined to the psi-gag-PR region.
Richardson J; Corbin A; Pozo F; Orsoni S; Sitbon M
J Virol; 1993 Sep; 67(9):5478-86. PubMed ID: 8350407
[TBL] [Abstract][Full Text] [Related]
17. Deletion of a GC-rich region flanking the enhancer element within the long terminal repeat sequences alters the disease specificity of Moloney murine leukemia virus.
Hanecak R; Pattengale PK; Fan H
J Virol; 1991 Oct; 65(10):5357-63. PubMed ID: 1895389
[TBL] [Abstract][Full Text] [Related]
18. An enhancer sequence instability that diversifies the cell repertoire for expression of a murine leukemia virus.
Spiro C; Li JP; Bestwick RK; Kabat D
Virology; 1988 Jun; 164(2):350-61. PubMed ID: 2835856
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus.
Nishigaki K; Hanson C; Thompson D; Yugawa T; Hisasue M; Tsujimoto H; Ruscetti S
J Virol; 2002 Feb; 76(3):1527-32. PubMed ID: 11773427
[TBL] [Abstract][Full Text] [Related]
20. In vivo footprinting of the enhancer sequences in the upstream long terminal repeat of Moloney murine leukemia virus: differential binding of nuclear factors in different cell types.
Granger SW; Fan H
J Virol; 1998 Nov; 72(11):8961-70. PubMed ID: 9765441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
